Lipoprotein(a) levels in familial hypercholesterolemia: An important predictor of cardiovascular disease independent of the type of LDL receptor mutation

Journal of the American College of Cardiology

Volumn 63, Issue 19, 2014, Pages 1982-1989

  Alonso, Rodrigo ^a   Andres, Eduardo ^b   Mata, Nelva ^c   Fuentes Jiménez, Francisco ^d   Badimón, Lina ^e   López Miranda, José ^d   Padró, Teresa ^e   Muñiz, Ovidio ^f   Díaz Díaz, Jose Luis ^g   Mauri, Marta ^h   Ordovás, Jose María ⁱ   Mata, Pedro ^j  

^a 28400 Madrid   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c Madrid Regional Authority   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e Institut Català de Ciències Cardiovasculars   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g Hospital Abente y Lago   (Spain)

^h HOSPITAL DE TERRASSA   (Spain)

ⁱ TUFTS UNIVERSITY   (United States)

^j Medicina Interna   (Spain)

more..

Author keywords

cardiovascular disease; familial hypercholesterolemia; LDL receptor mutations; lipoprotein(a)

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENE MUTATION; HETEROZYGOSITY; HUMAN; LDLR GENE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATHOGENESIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN FUNCTION; PREDICTION; RISK ASSESSMENT;

CARDIOVASCULAR DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; LDL RECEPTOR MUTATIONS; LIPOPROTEIN(A);

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEIN(A); MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; RECEPTORS, LDL;

EID: 84900529903     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.063     Document Type: Article

References (26)

1. J.L. Goldstein, H.H. Hobbs, and M.S. Brown Familial hypercholesterolemia C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, The Metabolic and Molecular Basis of Inherited Disease Vol. II 2001 McGraw-Hill New York, NY 2863 2913
2. J. Slack Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states Lancet 2 1969 1380 1382
3. R. Alonso, S. Castillo, and F. Civeira et al. Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases Med Clin (Barc) 118 2002 487 492
4. Scientific Steering Committee on behalf of the Simon Broome Register Group The risk of fatal coronary heart disease in familial hypercholesterolemia BMJ 3030 1991 893 896
5. A.C. Jansen, and Tanck MW. van Aalst-Cohen et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients J Intern Med 256 2004 482 490
6. B.G. Nordestgaard, M.J. Chapman, and K. Ray et al. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2010 2844 2853
7. S. Erqou, S. Kaptoge, and P.L. Perry et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
8. P.R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B.G. Nordestgaard Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study Circulation 117 2008 176 184
9. M. Seed, F. Hoppichler, and D. Reaveley et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia N Engl J Med 322 1990 1494 1499
10. P.R. de Sauvage Nolting, J.C. Defesche, R.J. Buirma, B.A. Hutten, P. Lansberg, and J.J. Kastelein Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia J Intern Med 253 2003 161 168
11. P. Hopkins, S. Stephenson, L. Wu, W. Riley, Y. Xin, and S. Hunt Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia Am J Cardiol 87 2001 547 553
12. D.T. Holmes, B.A. Schick, K.H. Humphries, and J. Frohlich Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia Clin Chem 51 2005 2067 2073
13. M.S. Nenseter, H.W. Lindvig, and T. Ueland et al. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia Atherosclerosis 216 2011 426 432
14. N. Mata, R. Alonso, and L. Badimon et al. Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) Lipids Health Dis 10 2011 94
15. R. Alonso, J.C. Defesche, and D. Tejedor et al. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform Clin Biochem 42 2009 899 903
16. J.M. Simó, J. Camps, F. Gómez, N. Ferré, and J. Joven Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). Population-based reference values in an area with low incidence of cardiovascular disease Clin Biochem 36 2003 129 134
17. R. Alonso, N. Mata, and S. Castillo et al. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors Atherosclerosis 200 2008 315 321
18. O. Wiklund, B. Angelin, and S.O. Olofsson et al. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolemia Lancet 335 1990 1360 1363
19. G. Utermann, F. Hoppichler, H. Dieplinger, M. Seed, G. Thompson, and E. Boerwinkle Defects in the low density lipoprotein receptor gene affect lipoprotein(a) levels: multiplicative interaction of two loci associated with premature atherosclerosis Proc Natl Acad Sci U S A 86 1989 4171 4174
20. A. Lingenhel, H.G. Kraft, and M. Kotze et al. Concentrations of the atherogenic Lp(a)are elevated in FH Eur J Hum Genet 6 1998 50 60
21. A.D. Mbewu, D. Bhatnagar, and P.N. Durrington et al. Serum Lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives and unrelated control populations Arterioscler Thromb 11 1991 940 946
22. E. Leitersdorf, Y. Friedlander, J.M. Bard, J.C. Fruchart, S. Eisenberg, and Y. Stein Diverse effect of ethnicity on plasma lipoprotein (a) levels in heterozygous patients with familial hypercholesterolemia J Lipid Res 32 1991 1513 1519
23. H.G. Kraft, A. Lingenhel, F.J. Raal, M. Hohenegger, and G. Utermann Lipoprotein(a) in homozygous familial hypercholesterolemia Arterioscler Thromb Vasc Biol 20 2000 522 528
24. G.R. Thompson Recommendations for the use of LDL apheresis Atherosclerosis 198 2008 247 255
25. R. Alonso, P. Mata, D. Zambón, N. Mata, and F. Fuentes-Jiménez Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes Expert Rev Cardiovasc Ther 11 2013 327 342
26. S. Tsimikas, and J.L. Hall Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies J Am Coll Cardiol 60 2012 716 721